Global Cell-free Protein Expression Market Size (2024 - 2029)

The cell-free protein expression market is experiencing growth driven by advancements in proteomics and genomics, alongside the increasing demand for rapid and efficient protein production methods. This market's expansion is supported by the advantages of cell-free systems, such as reduced workflow complexities and the ability to produce proteins without the constraints of living cells. The technology's application in personalized medicine and biological therapies further propels its adoption, as it offers significant benefits over traditional in vivo systems, including faster production times and enhanced experimental flexibility.

Market Size of Global Cell-free Protein Expression Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Cell-Free Protein Expression Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 266.82 Million
Market Size (2029) USD 354.38 Million
CAGR (2024 - 2029) 5.84 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Cell-Free Protein Expression Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Cell-free Protein Expression Market Analysis

The Global Cell-free Protein Expression Market size is estimated at USD 266.82 million in 2024, and is expected to reach USD 354.38 million by 2029, growing at a CAGR of 5.84% during the forecast period (2024-2029).

The market has a slightly positive impact due to the pandemic. Moreover, according to the article, "Harnessing proteomics could improve therapeutic approaches to COVID-19," published in November 2020, the development of therapeutic and preventive strategies requires an accurate understanding of proteins' role in the SARS-CoV-2 infection process and progression of COVID-19.

Furthermore, according to the article, "Scientists develop a high-throughput, cell-free screening platform for anti-SARS-CoV-2 antibody discovery," published in November 2021, Therapeutic monoclonal antibodies developed against the spike protein of SARS-CoV-2 have become a promising intervention to treat severely ill coronavirus disease 2019 (COVID-19) patients. However, the isolation, evaluation, and identification of the best antibody candidate require a series of time-consuming and labor-intensive experiments, including cloning, transfection, cell-based protein expression, protein purification, and critical assessment.

The significant factors for the growth of the cell-free protein expression market include the increasing R&D in proteomics and genomics, high prevalence of cancer and infectious diseases, and shorter-expression time and structural modification. Cell-free protein expression employs cell lysates to produce the desired recombinant proteins. The primary advantage of this technique is the aversion of workflow hurdles of maintaining cell culture or living cells. Cell lysates are produced by the breakdown and use of cellular components of eukaryotic or bacterial cells. Several cell-free protein expression systems are currently commercially available, based on E. coli, rabbit reticulocytes, wheat germs, human cell lines, and insect cells.

According to the article, 'Exploring the Potential of Cell-Free Protein Synthesis for Extending the Abilities of Biological Systems,' published in October 2019, Cell-free protein synthesis (CFPS) has the potential to overcome loopholes in the current in vivo production systems and is a promising tool in both primary and applied scientific research. It facilitates a simplified organization of desired experiments with various reaction conditions, making CFPS a powerful tool in biological research. It has been used to expand genetic code, assembly of viruses, and metabolic engineering to produce toxic and complex proteins. Subsequently, CFPS systems have emerged as a powerful technology for the high-throughput production of membrane proteins, enzymes, and therapeutics.

An in vitro protein expression system has significant advantages over living cell-based protein expression, including a shorter duration of the process, isotopic labeling of proteins, incorporation of non-natural amino acids, and optimization of protein complexes. In addition, the ability to enable high throughput production, the recent trend of more research in personalized medicine, and the growing need for biological therapies to manage cancer is significant driver for the adoption of cell-free protein expression techniques by pharmaceutical and biotechnology firms.

Cell-free Protein Expression Industry Segmentation

As per the scope of this report, cell-free protein expression or in vitro protein synthesis is a process that involves the production of the recombinant proteins in cell lysate solution, without using cell culture or living cells. Cell-free protein expression can be carried out using different cell lysates, such as those of E. coli, rabbit reticulocytes, wheat germs, human cells, and insect cells. The cell-free protein expression market are segmented By Products, Accessories and Consumables , Lysate Systems (E. Coli Lysate, Wheat Germ Extract Lysate, Rabbit Reticulocyte Lysate, Insect Cell Lysate, Human Cell Lysate and Other Lysate Systems), By Application (Enzyme Engineering, High Throughput Production, Protein Labeling, Protein-Protein Interaction and Other Applications) and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The report offers the value (in USD million) for the above segments.

By Products
Accessories and Consumables
Lysate Systems
E. Coli Lysate
Wheat Germ Extract Lysate
Rabbit Reticulocyte Lysate
Insect Cell Lysate
Human Cell Lysate
Other Lysate Systems
By Application
Enzyme Engineering
High Throughput Production
Protein Labeling
Protein-Protein Interaction
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Cell-free Protein Expression Market Size Summary

The cell-free protein expression market is poised for growth, driven by advancements in proteomics and genomics, alongside the increasing prevalence of cancer and infectious diseases. This market leverages cell lysates to produce recombinant proteins, offering advantages such as bypassing the complexities of maintaining live cell cultures. The technology is gaining traction due to its ability to facilitate high-throughput production and its application in personalized medicine and biological therapies. Various systems, including those based on E. coli, rabbit reticulocytes, and human cell lines, are commercially available, with E. coli lysates being particularly popular due to their high protein yield and adaptability. Despite some limitations in post-translational modifications, ongoing advancements are expected to sustain the growth of E. coli-based systems.

North America, particularly the United States, dominates the cell-free protein expression market, supported by a robust R&D infrastructure and favorable government policies. The region's market expansion is fueled by the rising incidence of chronic diseases like cancer and the growing demand for targeted therapies. The market is moderately consolidated, with key players such as Thermo Fisher Scientific Inc. and Merck KGaA actively expanding their portfolios through strategic acquisitions. These developments underscore the market's potential, as companies continue to enhance their offerings to meet the increasing demand for efficient and innovative protein expression solutions.

Explore More

Global Cell-free Protein Expression Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing R&D in the Fields of Proteomics and Genomics

      2. 1.2.2 Growing Burden of Cancer and Infectious Diseases

      3. 1.2.3 Shorter Expression Time and Structural Modification

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Protein Expression Systems

      2. 1.3.2 Lack of Effective Systems for Post-translational Modifications

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Products

      1. 2.1.1 Accessories and Consumables

      2. 2.1.2 Lysate Systems

        1. 2.1.2.1 E. Coli Lysate

        2. 2.1.2.2 Wheat Germ Extract Lysate

        3. 2.1.2.3 Rabbit Reticulocyte Lysate

        4. 2.1.2.4 Insect Cell Lysate

        5. 2.1.2.5 Human Cell Lysate

        6. 2.1.2.6 Other Lysate Systems

    2. 2.2 By Application

      1. 2.2.1 Enzyme Engineering

      2. 2.2.2 High Throughput Production

      3. 2.2.3 Protein Labeling

      4. 2.2.4 Protein-Protein Interaction

      5. 2.2.5 Other Applications

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Cell-free Protein Expression Market Size FAQs

The Global Cell-free Protein Expression Market size is expected to reach USD 266.82 million in 2024 and grow at a CAGR of 5.84% to reach USD 354.38 million by 2029.

In 2024, the Global Cell-free Protein Expression Market size is expected to reach USD 266.82 million.

Cell-free Protein Expression Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)